From the NYT's Peter Goodman:
It increasingly seems as if the policy makers attending like physicians to the American economy are peering into their medical kits and coming up empty, their arsenal of pharmaceuticals largely exhausted and the few that remain deemed too experimental or laden with risky side effects. The patient -- who started in critical care -- was showing signs of improvement in the convalescent ward earlier this year, but has since deteriorated. The doctors cannot agree on a diagnosis, let alone administer an antidote with confidence.

 Follow LA Observed on Twitter here
Follow LA Observed on Twitter here

 
   
   
   Mark Lacter created the LA Biz Observed blog in 2006. He posted 
until the day before his death on Nov. 13, 2013.
Mark Lacter created the LA Biz Observed blog in 2006. He posted 
until the day before his death on Nov. 13, 2013.